Clever Leaves

Once a cannabis pioneer, Clever Leaves Holdings Inc. (NASDAQ:CLVR) has announced its plan to voluntarily delist from NASDAQ and deregister its securities.  This financial move, approved by its Board of Directors, aims to terminate and suspend its reporting obligations to the Securities and Exchange...

Global medicinal cannabis company Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) reported late Thursday its financial and operating results for the first quarter of 2023. CEO Andres Fajardo highlighted the continued commercial momentum in core target markets such as Brazil,...

The House of Kush, a majority Black-owned business, is rooted in science and based on legacy strains by preserving both the history and integrity of the past for the future. By partnering with like-minded companies, House of Kush is expecting to expand into five additional states this year and...

Andres Fajardo is the CEO of Clever Leaves Holdings Inc. (NASDAQ: CLVR), one of the largest cannabis companies with operations in Canada, Colombia, Germany, Portugal and the United States. Clever is the first cannabis company in Latin America listed on Nasdaq with a ...

Clever Leaves has operations and investments in the United States, Canada, Colombia, Germany and Portugal. This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Widespread legalization and innovation are...

Stocks of Clever Leaves Holdings Inc. (NASDAQ: CLVRW) are soaring as of late Friday following reports indicating the U.S. House Rules Committee has scheduled a Monday afternoon meeting to prepare the MORE Act, a federal marijuana legalization bill, for floor action. Clever Leaves is...

Clever Leaves Holdings Inc. (NASDAQ: CLVR), a multinational operator and licensed producer of pharmaceutical-grade cannabinoids, announced Wednesday that it has officially entered the U.S. CBD market through the launch of its consumer-oriented CBD line JoySol. JoySol, the U.S. nutraceutical...

Photos by Clever Leaves The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Europe is now a booming and viable market for companies needing a conducive environment to start and grow their...

Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids reported its financial and operating results for the third quarter ended September 30, 2021. Third Quarter 2021 Highlights vs. Same Year-Ago...

During Benzinga Cannabis Capital Conference, several leaders of various cannabis companies gathered to discuss the continuous expansion of the cannabis market outside the U.S.   The panel included: Alvaro Torres, CEO of Khiron Life Sciences (OTC: KHRNF), a vertically...

Image Provided by Clever Leaves The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. For years, cannabinoids, the chemicals found in the cannabis plant, have been widely known for their...

Medical marijuana has been legalized in Mexico since June 2017 and, in 2018, Mexico’s Supreme Court of Justice ruled that banning the plant was unconstitutional. On April 30, 2021, Mexico's Congress failed to pass adult-use legalization orders that were handed down by five Supreme...

SPACs have been one of the hottest investment stories of 2020. The blank check, reverse merger vehicles have taken numerous private companies — as well as former public companies — public on major exchanges. Here is a look at some SPACs that are taking cannabis companies public or...

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Clever Leaves joined a panel of cannabis movers and shakers from across the globe at Benzinga’s Virtual Cannabis Capital Conference...

It’s been three years since Colombia issued Decree 613, regulating cannabis for medical and scientific use across the country. The program has been generally considered successful, and has helped establish a cannabis industry that is leading the region in terms of regulatory development...